Observational studyThe Journal of clinical endocrinology and metabolism2026
Effects of Puberty Suppression and Sex Steroids on Weight, BMI, and Lipid Profiles in Danish Transgender Adolescents.
Observational study in The Journal of clinical endocrinology and metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
contextCardiovascular health of the transgender population receiving hormone therapy (HT) has been a concern.
objectiveTo investigate weight, body mass index (BMI), and lipid profiles in a national cohort of transgender adolescents starting HT before 18 years of age.
methodsIn this observational study, 164 trans boys and 55 trans girls were followed longitudinally during HT. Gonadotropin-releasing hormone analog (GnRHa) was initiated either before or alongside sex steroid therapy. Anthropometry and lipid profiles were analyzed at the start of HT and at routine visits.
resultsBefore HT, overweight (BMI 1-2 standard deviation score [SDS]) and obesity (BMI ≥ 2 SDS) were found in 26.8% and 22.0% of trans boys, and in 5.7% and 5.7% of trans girls, respectively. BMI SDS correlated positively with total cholesterol, low-density lipoprotein (LDL), and triglycerides, and negatively with high-density lipoprotein (HDL). In trans boys and girls, high percentages had lipids above normal reference intervals; total cholesterol (12.5% and 6.1%), LDL (21.8% and 12.5%), and triglycerides (3.4% and 6.3%), and HDL below normal reference intervals (9.0% and 18.4%), respectively. During GnRHa monotherapy, there was a trend toward declining weight SDS, but BMI SDS and lipid profiles did not change consistently. After initiation of sex steroids, weight SDS, BMI SDS, and HDL decreased along with increased triglycerides in trans boys, and HDL increased in trans girls.
conclusionOverweight, obesity, and dyslipidemia were common in transgender adolescents before HT initiation. BMI did not deteriorate, but dyslipidemia worsened slightly during sex steroid therapy in trans boys but not in trans girls.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.